Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,464 | -38,777 | -32,105 | -18,193 | -90,908 |
| Depreciation Amortization | 1,439 | 1,101 | 814 | 435 | 2,359 |
| Accounts receivable | 5,547 | 5,587 | 5,400 | 5,644 | N/A |
| Accounts payable and accrued liabilities | 1,150 | -924 | -517 | -477 | -2,290 |
| Other Working Capital | 19,266 | 22,339 | 27,169 | 33,691 | -195 |
| Other Operating Activity | 649 | 1,058 | -920 | -3,113 | 21,281 |
| Operating Cash Flow | $-23,413 | $-9,616 | $-159 | $17,987 | $-69,753 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 45,099 | 32,215 | 1,322 | 9,543 | 63,111 |
| PPE Investments | -486 | -352 | -105 | -32 | -179 |
| Investing Cash Flow | $44,613 | $31,863 | $1,217 | $9,511 | $62,932 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,053 | 1,127 | 1,029 | 17 | 1,170 |
| Financing Cash Flow | $7,053 | $1,127 | $1,029 | $17 | $1,170 |
| Beginning Cash Position | 15,203 | 15,203 | 15,203 | 15,203 | 20,854 |
| End Cash Position | 43,456 | 38,577 | 17,290 | 42,718 | 15,203 |
| Net Cash Flow | $28,253 | $23,374 | $2,087 | $27,515 | $-5,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,413 | -9,616 | -159 | 17,987 | -69,753 |
| Capital Expenditure | -546 | -412 | -105 | -32 | -413 |
| Free Cash Flow | -23,959 | -10,028 | -264 | 17,955 | -70,166 |